CONMED (CON) trusts detail 130,000-share planned sale and recent large stock trades
Rhea-AI Filing Summary
CONMED Corporation affiliated trusts filed to permit the potential sale of 130,000 shares of common stock through UBS Financial Services Inc., with an indicated aggregate market value of $4,114,500.00, against 127,961,780 shares outstanding as of August 3, 2026.
The shares proposed for sale were originally acquired via private purchases of stock on February 5, 1997, February 23, 2005, and April 29, 2005, totaling 38,544, 588, and 90,868 shares, respectively. The filing also lists recent sales by The Rocco A Ortenzio Trust FBO Robert Ortenzio and The Revocable Trust of Rocco A Ortenzio, including blocks of 130,000 and 259,940 shares of common stock between May 8, 2026 and July 1, 2026, for aggregate consideration up to $7,939,763.32 on a single date.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Form 144 regulatory
Private Purchase of Stock financial
Revocable Trust financial
aggregate market value financial
AI-generated analysis. How Rhea-AI works. Not financial advice.